Thiazolidinediones News and Research

RSS
Thiazolidinediones are adjunctive therapies for diabetes mellitus (type 2) and related diseases.
Bristol-Myers Squibb, AstraZeneca commence SAVOR-TIMI 53 trial of ONGLYZA for type 2 diabetes

Bristol-Myers Squibb, AstraZeneca commence SAVOR-TIMI 53 trial of ONGLYZA for type 2 diabetes

Joint science advisory issues messages for diabetics at risk for heart disease and stroke

Joint science advisory issues messages for diabetics at risk for heart disease and stroke

FDA approves Novo Nordisk's Victoza for type 2 diabetes

FDA approves Novo Nordisk's Victoza for type 2 diabetes

Positive results from study comparing exenatide once weekly to BYETTA

Positive results from study comparing exenatide once weekly to BYETTA

Sulphonylureas, an antidiabetic drug, carries greater risk of heart failure and death compared to metformin

Sulphonylureas, an antidiabetic drug, carries greater risk of heart failure and death compared to metformin

New diabetes algorithm released by AACE for the management of type 2 diabetes

New diabetes algorithm released by AACE for the management of type 2 diabetes

FDA approves Daiichi Sankyo's sNDA for Welchol

FDA approves Daiichi Sankyo's sNDA for Welchol

Safety profiles of JANUVIA and JANUMET drugs established through clinical development program

Safety profiles of JANUVIA and JANUMET drugs established through clinical development program

European CHMP recommends Merck's JANUVIA and JANUMET as add-on to insulin

European CHMP recommends Merck's JANUVIA and JANUMET as add-on to insulin

Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: Population-based cohort study

Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: Population-based cohort study

NDA for Exenatide once weekly accepted for FDA review

NDA for Exenatide once weekly accepted for FDA review

Discovery of genetic markers to help fight diabetes

Discovery of genetic markers to help fight diabetes

Diabetes drug pioglitazone shows potential against multiple sclerosis

Diabetes drug pioglitazone shows potential against multiple sclerosis

People with Ala12 gene variant need to watch out for high fat in their diets

People with Ala12 gene variant need to watch out for high fat in their diets

Thiazolidinediones doubles risk of fractures in women

Thiazolidinediones doubles risk of fractures in women

New evidence shows that the heart beats to its own drummer

New evidence shows that the heart beats to its own drummer

Risks associated with diabetes drug rosiglitazone may be higher than those with pioglitazone

Risks associated with diabetes drug rosiglitazone may be higher than those with pioglitazone

FDA continues review of Takeda's NDA for Alogliptin

FDA continues review of Takeda's NDA for Alogliptin

Advances in the management of diabetes mellitus

Advances in the management of diabetes mellitus

Thiazolidinediones - diabetes drugs carry significant cardiovascular risks

Thiazolidinediones - diabetes drugs carry significant cardiovascular risks